Overprescribing cancer drugs 'not tenable way forward' - experts

However the UK is not participating in this trend and has fallen behind European neighbours in the practice. The Lancet Oncology Commission made the conclusions having studied cancer treatment and its price. In the latest issue of the magazine the Commission said: "The burden of cancer is growing rapidly, and the disease is becoming a major challenge for all developed countries. "This is not simply due to an increase in absolute numbers or need for optimised treatments, rather it relates to the unsustainable rate of increase in expenditure on cancer within health-care systems." ...